Clinical Trial Update: Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating controlled cessation of colchicine therapy in familial Mediterranean fever patients with a single MEFV gene mutation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Mediterranean Fever

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Familial Mediterranean Fever | Phase 2 | Status: UNKNOWN